Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$171,319,279
+$23,976,547 QoQ
Shares Held
680,811
+0.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#174
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. ABBV ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
357,284 | $428,537,182 | |
| 2 | JNJ |
Johnson & Johnson
|
1,192,228 | $302,790,144 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
680,811 | $171,319,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,305,364 | $167,739,274 | |
| 5 | PFE |
Pfizer Inc
|
6,943,719 | $167,204,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,414,008 | $81,475,140 | |
| 7 | AMGN |
Amgen Inc
|
209,837 | $75,986,174 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
525,655 | $66,411,252 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,319,279 | 680,811 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $147,342,732 | 677,469 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $143,649,834 | 628,692 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $201,938,073 | 872,152 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $162,266,033 | 874,184 | Shares | Sole | 2025-12-02 | |
| 2025-03-31 | $187,004,979 | 892,540 | Shares | Sole | 2025-12-02 | |
| 2024-12-31 | $146,039,545 | 821,832 | Shares | Defined | 2025-12-09 | |
| 2024-09-30 | $82,360,218 | 417,056 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $73,542,115 | 428,767 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $69,965,915 | 384,217 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $53,699,894 | 346,518 | Shares | Defined | 2025-12-09 | |
| 2023-09-30 | $49,825,540 | 334,265 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $39,450,155 | 292,809 | Shares | Defined | 2025-12-09 | |
| 2023-03-31 | $45,869,553 | 287,818 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $37,871,686 | 234,340 | Shares | Defined | 2025-12-09 | |
| 2022-09-30 | $33,763,880 | 251,575 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $36,383,923 | 237,555 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $51,292,251 | 316,404 | Shares | Defined | 2025-12-09 | |
| 2021-12-31 | $42,286,097 | 312,305 | Shares | Sole | 2025-12-29 | |
| 2021-09-30 | $39,282,585 | 364,166 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $35,178,896 | 358,215 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $34,694,357 | 320,591 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $35,169,736 | 328,229 | Shares | Defined | 2025-12-29 | |
| 2020-09-30 | $7,064,308 | 80,652 | Shares | Sole | 2025-12-29 | |
| 2020-06-30 | $13,146,399 | 133,901 | Shares | Sole | 2025-12-29 | |
| 2020-03-31 | $8,211,910 | 107,782 | Shares | Defined | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||